BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts
about
Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-AnalysisGlycolysis determines dichotomous regulation of T cell subsets in hypoxiaMelatonin downregulates nuclear receptor RZR/RORγ expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivoClinically Evaluated Cancer Drugs Inhibiting Redox Signaling.Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenanceThe expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment.Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer.Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer.Targeting the long noncoding RNA MALAT1 blocks the pro-angiogenic effects of osteosarcoma and suppresses tumour growth.Dual-target cancer theranostic for glutathione S-transferase and hypoxia-inducible factor-1α inhibition.AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization.
P2860
Q26749393-011D40D3-0B23-4F0C-9DBA-563F5B0CCF6EQ37042215-94DD9F80-ADC7-4EA0-91FA-A1690B19FBC8Q37108056-459F7802-BE02-4FDC-B3E6-338DBED037F3Q38777221-23A2E234-5201-48C2-A5C3-EF27E200F838Q38813967-A614B7A4-8151-4410-AABE-99D1C0E368E1Q38819393-3F32423B-BB7D-47A4-B38A-8BD6EF46FCDCQ41367891-0D634B4E-DD4A-4FAE-B231-C71A668DC737Q42317488-083236AC-D742-49F6-A53E-E93A9C44A0B2Q47095623-1FD0C0F8-ECB8-4739-94BC-281FE808387EQ47372909-DF3F9B37-438C-4476-A51D-04D435A3B30AQ48022535-35E63C62-B817-4D4E-9848-704C16FAB719
P2860
BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@ast
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@en
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@nl
type
label
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@ast
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@en
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@nl
prefLabel
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@ast
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@en
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@nl
P2093
P2860
P356
P1433
P1476
BAY 87-2243, a novel inhibitor ...... head and neck human xenografts
@en
P2093
Ala Yaromina
Holger Hess-Stumpp
Kerstin Brüchner
Kerstin Unterschemmann
Kristin Gurtner
Linda Helbig
P2860
P2888
P356
10.1186/1748-717X-9-207
P577
2014-09-19T00:00:00Z
P6179
1035365313